-
Founded in:
1997-07-25 -
Country:
China -
Address:
Shanghai Chongming Changzheng General Company Science and Technology Park -
Tax NO.:
913102301344624891 -
Registered Funds:
50 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Yeast extract |
Rich in B vitamins, it has an auxiliary therapeutic effect on indigestion
More
Rich in B vitamins, it has an auxiliary therapeutic effect on indigestion |
40.0%Label quantity | 8013-01-2 | 4 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ginkgo biloba extract |
|
90045-36-6 | 4 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Olmesartan Medoxomil |
Olmesartan medoxomil is a prodrug that is absorbed and hydrolyzed into olmesartan through the gastrointestinal tract. Olmesartan is a selective angiotensin II type 1 receptor (AT1) antagonist that inhibits the vasoconstriction effect of angiotensin II by blocking the binding of angiotensin II to the AT1 receptor of vascular smooth muscle, without affecting bradykinin. Its action is independent of the ATⅡ synthesis pathway. Blocking the angiotensin II receptor will inhibit the negative feedback regulation mechanism of angiotensin II on renin secretion, but the increased plasma renin activity and circulating angiotensin II concentration do not affect its antihypertensive effect.
More
Olmesartan medoxomil is a prodrug that is absorbed and hydrolyzed into olmesartan through the gastrointestinal tract. Olmesartan is a selective angiotensin II type 1 receptor (AT1) antagonist that inhibits the vasoconstriction effect of angiotensin II by blocking the binding of angiotensin II to the AT1 receptor of vascular smooth muscle, without affecting bradykinin. Its action is independent of the ATⅡ synthesis pathway. Blocking the angiotensin II receptor will inhibit the negative feedback regulation mechanism of angiotensin II on renin secretion, but the increased plasma renin activity and circulating angiotensin II concentration do not affect its antihypertensive effect. |
144689-63-4 | 102 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Metoprolol tartrate |
Extract from the above information
More
Extract from the above information |
56392-17-7 | 49 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Moclobemide |
This product is a monoamine oxidase inhibitor antidepressant. It works by reversibly inhibiting type A monoamine oxidase in the brain, thereby increasing the levels of norepinephrine, dopamine and 5-hydroxytryptamine in the brain, playing an antidepressant role. It has the characteristics of fast action and rapid recovery of monoamine oxidase activity after discontinuation of the drug.
More
This product is a monoamine oxidase inhibitor antidepressant. It works by reversibly inhibiting type A monoamine oxidase in the brain, thereby increasing the levels of norepinephrine, dopamine and 5-hydroxytryptamine in the brain, playing an antidepressant role. It has the characteristics of fast action and rapid recovery of monoamine oxidase activity after discontinuation of the drug. |
71320-77-9 | 6 |